Theravance Biopharma, Inc. has just announced the sale of its remaining royalty interest in Trelegy Ellipta to GSK for $225 ...

Antibody drugs that target the PD-1 and VEGF pathways are in the ASCO spotlight, while doctors wrestle with how to use a new ...

U.S. drugmaker Bristol Myers Squibb announced on Monday a $1.5 billion upfront payment to partner with Germany's BioNTech , ...

The act targets the health insurance middlemen that manage members' prescription drug benefits on behalf of the plans, ...

Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

To reduce pharmaceutical contamination in waterways ... Every one of them makes a difference. Kiley Price is a reporter at Inside Climate News, with a particular interest in wildlife, ocean ...

It also orders the Secretary of Commerce and other agency heads to review and consider actions regarding the export of pharmaceutical drugs or ingredients that may contribute to price differences.